Stock 600211 TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tibet Rhodiola Pharmaceutical Holding Co.

Equities

600211

CNE000000ZW7

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
36.6 CNY +0.49% Intraday chart for Tibet Rhodiola Pharmaceutical Holding Co. +2.81% -2.50%
Apr. 26 Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 26 Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The Company conducts its businesses primarily in South China, North China, East China, Central China and overseas markets.

Number of employees: 601

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Trade
97.3 %
2,474 96.8 % 3,048 97.3 % +23.23%
Pharmaceutical Manufacturing
69.2 %
1,765 69.1 % 2,169 69.2 % +22.91%
Inter-segment Elimination
-66.7 %
-1,693 -66.3 % -2,089 -66.7 % +23.37%
Other Business
0.2 %
10 0.4 % 6 0.2 % -35.64%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
97.9 %
2,415 94.9 % 3,070 97.9 % +27.13%
Overseas
2.1 %
130 5.1 % 64 2.1 % -50.48%

Managers

Managers TitleAgeSince
Yuan Dong Guo CEO
 Chief Executive Officer 54 -
Jun Chen DFI
 Director of Finance/CFO 46 11-12-31
Yu Cheng Zhou BRD
 Director/Board Member 42 -
Li Li Wen IRC
 Investor Relations Contact 44 04-05-31
Meng Peng PRN
 Corporate Officer/Principal 52 -
Lan Liu SEC
 Corporate Secretary 57 -

Members of the board

Members of the board TitleAgeSince
Da Bin Chen CHM
 Chairman 68 -
Yu Cheng Zhou BRD
 Director/Board Member 42 -
San Yan Wu BRD
 Director/Board Member 43 -
Lie Yi Ma BRD
 Director/Board Member 55 -
Meng Peng PRN
 Corporate Officer/Principal 52 -
Yu Zhang BRD
 Director/Board Member 48 21-12-26
Tian Tian Tang BRD
 Director/Board Member 42 03-12-31
Jia Yun Man BRD
 Director/Board Member 54 20-04-01
Ting Zhang BRD
 Director/Board Member 36 -
Yu Fang Li BRD
 Director/Board Member 46 21-12-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 247,937,843 93,941,764 ( 37.89 %) 0 37.89 %

Shareholders

NameEquities%Valuation
CHINA MEDICAL SYSTEM HOLDINGS LIMITED
37.36 %
92,618,560 37.36 % 566 M ¥
Da Bin Chen
17.78 %
44,072,000 17.78 % 269 M ¥
Beijing New Phoenix City Real Estate Develoment Co. Ltd.
3.190 %
7,910,000 3.190 % 48 M ¥
Autonomous Region of Tibet
1.988 %
4,928,000 1.988 % 30 M ¥
China Southern Asset Management Co., Ltd.
1.576 %
3,906,424 1.576 % 24 M ¥
Zhong Ou Asset Management Co., Ltd
1.550 %
3,843,975 1.550 % 24 M ¥
Fullgoal Fund Management Co., Ltd.
0.8444 %
2,093,710 0.8444 % 13 M ¥
JPMorgan Asset Management (China) Co Ltd.
0.6882 %
1,706,249 0.6882 % 10 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.6183 %
1,532,900 0.6183 % 9 M ¥
Chong Zhong Li
0.5243 %
1,300,000 0.5243 % 8 M ¥

Company contact information

Tibet Rhodiola Pharmaceutical Holding Co.

3 Guangzhou Road, Zone A Lhasa Economic & Tech Dev Zone

850000, Chengdu

+

http://www.xzyy.cn
address Tibet Rhodiola Pharmaceutical Holding Co.(600211)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Tibet Rhodiola Pharmaceutical Holding Co.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
36.6
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. Stock Tibet Rhodiola Pharmaceutical Holding Co.
-2.50% 1.62B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.97% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.59% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.70% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.62% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-4.30% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600211 Stock
  4. Company Tibet Rhodiola Pharmaceutical Holding Co.